Healthcare >> CEO Interviews >> September 30, 2020
Interview with the CEO: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)
Vincent Angotti is CEO and a member of the board of directors at AcelRx Pharmaceuticals, Inc. Earlier, he was CEO of XenoPort, Inc., a biopharmaceutical company focused on the development of treatments for neuropathic pain and other neurological disorders. Prior to that, Mr. Angotti was Senior Vice President of Sales and Marketing at Reliant Pharmaceuticals. He is a graduate of Cornell University and received an MBA, with honors, from Columbia University. Profile
Word count: 3,776
TWST: Could you tell me about the company?
Mr. Angotti: Sure. Our company, AcelRx, was started by Dr. Pamela Palmer, who is a Stanford medical